125 related articles for article (PubMed ID: 8450473)
1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
[TBL] [Abstract][Full Text] [Related]
3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
Spurney RF; Onorato JJ; Albers FJ; Coffman TM
Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
[TBL] [Abstract][Full Text] [Related]
5. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
6. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
10. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
[TBL] [Abstract][Full Text] [Related]
11. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
13. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
14. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
15. Characterization of (5Z)-7-[3-endo-[(4-iodophenylsulfonyl) amino] -bicyclo[2.2.1]hep-2-exo-yl]heptenoic acid (IS-145) as an antagonist for the study of thromboxane A2 receptor.
Kan WM; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):439-45. PubMed ID: 8341721
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
Folger WH; Halushka PV; Wilcox CS; Guzman NJ
Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
Armstrong RA; Humphrey PP; Lumley P
Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
[TBL] [Abstract][Full Text] [Related]
19. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
20. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
